Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

How COVID-19 could benefit tuberculosis and HIV services in South Africa

"The biological interactions between tuberculosis, HIV, and COVID-19, as well as health system factors contribute to the impact of COVID-19 on vulnerable populations." This paper explores how to improve health care by putting systems in place that will allow community support, build home-based care, self-administered tuberculosis therapy and further decentralised medication pick-up.

Original publication



Alumni publications


The Lancet

Publication Date


Total pages



Tuberculosis , HIV, COVID-19, Community-based treatment, screening and testing, multimonth antiretroviral therapy , Medical triage , community health workers